Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Liver
Study Phase
Phase 3
Study Completion Date
May 2015
NCT01015833Uploaded 10-21-2022
Access via NCI by Request
PDS UID: nci-data-499
Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Files: NCT01015833-D1
Data DictionaryNCT01015833-D1-Data-Dictionary_2.pdf
DATANCT01015833-D1-Dataset_1.csv
OTHERREADME.pdf